Indian pharmaceutical industry News

 Maharashtra Governor C.V. Rao on Saturday asked the Indian pharmaceutical industry to develop drugs for lifestyle diseases like diabetes, hypertension, cardiovascular ailments and tuberculosis, among others.

The government is expected to soon take a decision on liberalising foreign direct investment (FDI) policy for the cash-starved medical devices sector.

The US Food and Drug Administration (USFDA) has issued a warning letter to Ahmedabad-based Cadila Pharmaceuticals for violating current good manufacturing practice norms at its Ankleshwar plant in Gujarat.